Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-09-11Clinical Trial Update: Work Activity Augmented by Cognitive Rehabilitation for Schizophrenia [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating work activity augmented by cognitive rehabilitation in schizophrenia and schizoaffective disorder.
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
This clinical trial update discusses a completed study examining whether antipsychotic treatment for schizophrenia and related conditions af…
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Cognitive Behavioral Social Skills Training in Early Onset Psychosis [NA]
Clinical trial update on Cognitive Behavioral Social Skills Training for early onset psychosis, including schizophrenia, schizoaffective dis…
-
FDA approval · 2017-08-11FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved Janssen's supplemental application for INVEGA (paliperidone), expanding its approved indications.
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder [Phase 2]
Phase 2 trial update for NBI-98854 (valbenazine) in tardive dyskinesia in patients with schizophrenia or schizoaffective disorder; results w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: Biomarkers in Schizophrenia [Phase 2]
Phase 2 biomarker study in schizophrenia and schizoaffective disorder; the trial has completed and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Cognitive Remediation Therapy Within a Secure Forensic Setting [NA]
The trial evaluated cognitive remediation therapy in a secure forensic setting for schizophrenia or schizoaffective disorder and is marked a…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Prevention of Weight Gain in Early Psychoses [NA]
A completed clinical trial update examining strategies to prevent weight gain in individuals with early psychosis.
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Cognitive Skills Training Using Computer for Patients With Severe Mental Illness [Phase 4]
Phase 4 clinical trial evaluating computer-based cognitive skills training for schizophrenia and schizoaffective disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness [Phase 1]
Phase 1 clinical trial at Rutgers explored strategies to enhance motivation to quit smoking in individuals with schizophrenia or schizoaffec…
-
FDA approval · 2017-06-30FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for a generic quetiapine fumarate by Alembic Pharmaceuticals Limited.
-
FDA approval · 2017-06-30FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Macleods Pharmaceuticals Limited to market quetiapine fumarate. The approval covers a generic ve…
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Psychosocial Intervention to Reduce Self-stigma and Improve Quality of Life Among People With Mental Illness in Chile [NA]
The University of Chile conducted a completed clinical trial evaluating a psychosocial intervention to reduce self-stigma and improve qualit…
-
CLINICAL_TRIALS research · 2017-06-20Clinical Trial Update: Financial Incentives to Improve Acceptance of Antipsychotic Injections [NA]
This clinical trial update explores using financial incentives to improve acceptance of antipsychotic injections in patients with schizophre…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia [Phase 2]
Phase 2 clinical trial evaluating cannabidiol for cognitive dysfunction in schizophrenia has completed. Results were posted in 2017-06-08.
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-treated Patients With Schizophrenia [NA]
A completed clinical trial evaluated QTc interval changes using continuous Holter ECG in patients treated with antipsychotic drugs for schiz…
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Serotonin 1A Agonists and Cognition in Schizophrenia [Phase 3]
The document reports the completion of a Phase 3 trial evaluating a serotonin 1A agonist's effect on cognition in people with schizophrenia …
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents [Phase 2]
Phase 2 study evaluating lurasidone in antipsychotic-naive or quasi-naive children and adolescents with schizophrenia-spectrum and mood diso…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia [Phase 3]
This clinical trial update reports a Phase 3 study evaluating D-serine for negative symptoms and cognitive deficits in schizophrenia, with r…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia) [NA]
A clinical trial (RISE) evaluating rehabilitation interventions for people with schizophrenia in Ethiopia has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study
A six-year follow-up update from a clinical trial studying anomalous self-experience in first-episode psychosis, reporting long-term outcome…
-
FDA approval · 2017-04-25FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Clozapine submitted by Mylan Pharmaceuticals Inc., granting updated marketing authorization for …
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging [NA]
A completed Vanderbilt-sponsored clinical trial update describes using fMRI to quantify abnormal cortical activation associated with auditor…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders [Phase 2]
Phase 2 clinical trial exploring glycine metabolism mutation neurobiology in psychotic disorders has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Oxytocin Treatment of Schizophrenia [NA]
A completed clinical trial evaluating oxytocin as a treatment for schizophrenia, with results posted in 2017.